Industry Pushes CMS For Details On Centralized Coverage Review Of IDE Trials-graysheet: Some device companies say they generally support CMS’ proposal to centralize coverage review of investigational device exemption studies, while others want to retain the current Medicare Administrative Contractor-based coverage process. But virtually all industry stakeholders providing feedback to CMS say that if the agency does switch to centralized review, it must first offer a lot more detail about how the process would work.
